Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
39 results
  1. Key Question 4: Supplements Versus Placebo for Cognition, Function, and Quality of Life - Diagnosis and Treatment of ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556562
    ... rated high ROB , and results were not analyzed: Ginkgo biloba (6 trials), acetyl-l-carnitine (5 trials), ginseng (3 trials), curcumin (2 ...
  2. INCLUDED/EXCLUDED STUDY INFORMATION TABLES FOR QUANTITATIVE REVIEWS - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK55450
    ... 165. [ PubMed : 254898 ] ISRAEL1987 (Published Data Only) Israel L, Dell’Accio E, Martin G, Hugonot R. Ginkgo biloba extract and memory training programs. Comparative assessment on ...
  3. Detailed Methods - Screening for Impaired Visual Acuity in Older Adults - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK350375
    ... from another publication) [ PubMed : 23152282 ] Lebuisson DA, Leroy L, Rigal G. Treatment of senile macular degeneration with ginkgo biloba extract. A preliminary double-blind drug vs. placebo ...
  4. NLM Digital Collections - Management of patients with dementia : a national clinical guideline 
    Publication: Edinburgh, Scotland : SIGN, [2006]
    resource.nlm.nih.gov/101271578
    ... 1283-90. 130. Kurz A, Van Baelen B. Ginkgo biloba compared with cholinesterase 108. Rockwood K, Mintzer J, Truyen L, Wessel T, Wilkinson D. Effects of inhibitors in ...
  5. Included References - Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556548
    ... 2055. PMID: 18537221. [ PubMed : 18537221 ] [ CrossRef ] 224. Schneider LS, DeKosky ST, Farlow MR, et al. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer’s type. ...
  6. Excluded References - Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556577
    ... available in English [ PubMed : 24747504 ] 36. Klement S. ... 37. Kline T, Duskin L. Placebo-controlled studies and the need for expanded ...
  7. CLINICAL EVIDENCE –FOREST PLOTS - Autism - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK374178
    ... behaviour that challenges as a direct outcome Figure Ginkgo biloba and risperidone versus placebo and risperidone for behaviour ... system disorders Vascular disorders Adverse events associated with ginkgo biloba and risperidone versus placebo and risperidone Day time ...
  8. Results - Medical Therapies for Children With Autism Spectrum Disorder—An Update - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK448267
    ... 20%) in the placebo group (p=0.02). Ginkgo Biloba . In one RCT comparing Ginkgo biloba plus risperidone with risperidone plus placebo, investigators found ...
  9. Nutraceutical Interventions - Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and ... 
    https://www.ncbi.nlm.nih.gov/books/NBK442432
    ... PJ, et al. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer’s disease ( ... BE, O’Meara ES, Carlson MC, et al. Ginkgo biloba for preventing cognitive decline in older adults: a ...
  10. pdfWinter 2001 
    https://www.ncbi.nlm.nih.gov/books/NBK2592/bin/winter01.pdf
    ... database and you come across an entry for Ginkgo biloba . You may have heard of this plant many ... Entrez databases. Let’s take a look at the Ginkgo biloba example once again. To get to the record, ...
previous · 1 · 2 · 3 · next